Based on the previously described finding of a co-staining for CCRL1, SLFN13, SKI, Cables1, and DCHS1 with stemness markers, respectively, we examined the gene expressions of OCT4, Sox2, and KLF4 in human GBM ex vivo samples. The gene discussed is SLFN13; the disease is glioblastoma.